Jazz Pharmaceuticals to open a new production facility for cannabis-based medications

             London, United Kingdom (CU)_ Jazz Pharmaceuticals has revealed the opening of its new advanced manufacturing facility at Sittingbourne’s Kent Science Park (KSP). The facility will be used to produce cannabis-based medications that have been licensed by regulatory authorities. Jazz Pharmaceuticals and its branch GW Pharmaceuticals have planned the facility with environmental regulation in mind and have said that this will continue throughout the plant’s construction and operation. This will involve the construction of…